newsfilter
← Earnings
Earnings Releases·

Accuray — Fiscal 2027 First Quarter Earnings Summary

  • Total net revenue declined 8% year-over-year to $86.5 million, driven by a 26% drop in product revenue to $27.3 million, while service revenue rose 4% to $59.2 million; gross product orders fell 50% to $19.8 million with a book-to-bill ratio of 0.7.
  • Adjusted EBITDA improved to a positive $2.5 million from a negative $4.1 million in the prior year, excluding a $35.4 million non-cash goodwill impairment charge and a $59.6 million non-cash gain on debt extinguishment.
  • The company executed a financing transaction with TCW involving a $40 million debt-for-equity exchange, reducing long-term debt to $94.972 million and increasing cash reserves to $50.4 million, while management continues to provide no formal fiscal 2027 revenue or EBITDA guidance.
  • Strategic priorities for fiscal 2027 focus on executing cost efficiencies, converting customer engagement into product orders, and advancing partnerships with RaySearch and Samsung NeuroLogica, though order backlog remains 31% lower year-over-year at $272.0 million.
Company
ACCURAY INC
Sector
Healthcare
Industry
Medical Devices